全球神經刺激設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計神經刺激設備市場規模將從 2025 年的 124.8 億美元成長到 2034 年的 366.2 億美元，2026 年至 2034 年的複合年成長率為 12.71%。

受神經系統疾病先進治療方法需求不斷成長的推動，全球神經刺激設備市場正經歷強勁成長。神經刺激設備利用電脈衝刺激神經系統的特定區域，進而緩解慢性疼痛、帕金森氏症、癲癇和憂鬱症症狀。由於神經刺激器為對傳統藥物療法反應不佳的患者提供了有效的治療選擇，因此醫療專業人員對其應用正在迅速增加。

推動該市場擴張的因素有很多。神經系統疾病和慢性疼痛的日益普遍，增加了對創新治療方案的需求。此外，人們對微創療法的認知也不斷提高，也促使患者和醫療專業人員考慮使用神經刺激設備。持續的技術進步，例如電池續航時間的延長、無線編程以及植入式設備的小型化，也為市場成長提供了支援。

隨著神經科學和醫療技術研究的不斷深入，神經刺激設備的市場前景十分廣闊。對醫療創新投入的增加以及神經系統專科治療的普及將進一步推動其應用。此外，能夠提供更精準刺激的新一代設備的研發有望改善治療效果，並為市場創造新的機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球神經刺激設備市場：依產品分類

• 市場分析、洞察與預測
• 深部腦部刺激器
• 胃電刺激設備
• 脊髓刺激設備
• 薦骨神經刺激器
• 迷走神經刺激設備
• 經皮電神經刺激（TENS）
• 其他產品

第5章 全球神經刺激設備市場：依應用分類

• 市場分析、洞察與預測
• 疼痛管理
• 癲癇
• 自發性震顫
• 尿失禁和糞便失禁
• 憂鬱症
• 肌張力不全症
• 胃輕癱
• 帕金森氏症
• 其他用途

第6章 全球神經刺激設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • BioControl Medical
  • Boston Scientific Corporation
  • ElectroCore Inc
  • Endostim
  • Helbling Holding AG
  • Innovative Health Solutions Inc
  • Laborie Inc
  • LivaNova PLC
  • Medtronic Plc
  • MicroTransponder
  • Neuronetics Inc
  • Parasym Ltd
  • RS Medical

The Neurostimulation Devices Market size is expected to reach USD 36.62 Billion in 2034 from USD 12.48 Billion (2025) growing at a CAGR of 12.71% during 2026-2034.

The global neurostimulation devices market is experiencing strong growth due to increasing demand for advanced treatments for neurological disorders. Neurostimulation devices use electrical impulses to stimulate specific areas of the nervous system in order to manage conditions such as chronic pain, Parkinson's disease, epilepsy, and depression. Healthcare providers are increasingly adopting these devices as they offer effective treatment options for patients who do not respond well to conventional medications.

Several factors are driving the expansion of this market. The rising prevalence of neurological disorders and chronic pain conditions is increasing the demand for innovative treatment solutions. In addition, growing awareness about minimally invasive therapies is encouraging patients and healthcare professionals to consider neurostimulation devices. Continuous technological advancements, including improved battery life, wireless programming, and smaller implantable devices, are also supporting market growth.

The future of the neurostimulation devices market appears highly promising as research in neuroscience and medical technology continues to advance. Increasing investments in healthcare innovation and expanding access to specialized neurological treatments will likely support wider adoption. Furthermore, the development of next-generation devices capable of providing more precise stimulation is expected to enhance treatment effectiveness and create new opportunities in the market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Deep brain stimulator
• Gastric electric stimulator
• Spinal cord stimulator
• Sacral nerve stimulator
• Vagus nerve stimulator
• Transcutaneous electrical nerve stimulation (TENS)
• Other products

By Application

• Pain management
• Epilepsy
• Essential tremor
• Urinary and fecal incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson's disease
• Other applications

COMPANIES PROFILED

• Abbott Laboratories, Aleva Neurotherapeutics SA, BioControl Medical, Boston Scientific Corporation, ElectroCore Inc, Endostim, Helbling Holding AG, Innovative Health Solutions Inc, Laborie Inc, LivaNova PLC, Medtronic plc, MicroTransponder, Neuronetics Inc, Parasym Ltd, RS Medical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Deep brain stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Gastric electric stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Spinal cord stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sacral nerve stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Vagus nerve stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Transcutaneous electrical nerve stimulation (TENS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Other products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROSTIMULATION DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Pain management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Epilepsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Essential tremor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Urinary and fecal incontinence Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Depression Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Dystonia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Gastroparesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Parkinson's disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Other applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROSTIMULATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEUROSTIMULATION DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 Aleva Neurotherapeutics S.A
  • 8.2.3 BioControl Medical
  • 8.2.4 Boston Scientific Corporation
  • 8.2.5 ElectroCore Inc
  • 8.2.6 Endostim
  • 8.2.7 Helbling Holding AG
  • 8.2.8 Innovative Health Solutions Inc
  • 8.2.9 Laborie Inc
  • 8.2.10 LivaNova PLC
  • 8.2.11 Medtronic Plc
  • 8.2.12 MicroTransponder
  • 8.2.13 Neuronetics Inc
  • 8.2.14 Parasym Ltd
  • 8.2.15 RS Medical